Melanie Cox


Cognitive Behavioural Psychotherapist


Based at Cleckheaton & Pudsey


Psychotherapist Melanie gained an MSc in Cognitive Behavioural Psychotherapy in 2012 and has been practising Cognitive and Behavioural Therapies since 2004. Melanie is a member of the British Association for Behavioural and Cognitive Psychotherapies (11333073) and Nursing and Midwifery Council (98C1972E).


Melanie has 13 years of experience working with NHS clients in a variety of mental health setting. During the past 6 years she has worked in a secondary care Psychological Therapies Service with clients who have complex or severe psychological difficulties. These include anxiety disorders, depression, Post Traumatic Stress Disorder, Obsessive Compulsive Disorder, bereavement issues and complex traumas following childhood abuse.


Melanie is able to tailor therapy around individual needs and routinely offers, Cognitive Behavioural Therapy (CBT), Behavioural Therapy, Eye Movement Desensitisation Reprocessing (EMDR), Compassion Focussed Therapy and Mindfulness.  Melanie specialises in Acceptance and Commitment Therapy (ACT), which enables people to reconnect with aspects of their lives they care about and teaches new skills to respond in more helpful ways to painful thoughts and feelings.


Melanie formed and co-chairs the South and West Yorkshire ACT Special Interest Group. She has also been the chief investigator researching the effectiveness of trans-diagnostic ACT groups and runs workshops teaching ACT.


In her spare time Melanie plays drums in a band and enjoys rock climbing and spending time with her young family.

Northern Clinical Psychology Services


Arrange a consultation...


Contact us now for an initial consultation in complete confidence at a time and place that suits you. We have clinics across Yorkshire and Newcastle. You can reach us on:


Jane Guymer
Senior Team Administrator 

0800 622 6266



Alternatively, you can follow us on Social Media using the buttons below:

UK Health Centre
Blue light triggers memory and emphatic fear in mice via a non-invasive approach (Tue, 21 Jan 2020)
Researchers have engineered an improved biological tool that controls calcium (Ca2+) levels in the brain via blue light. This monster-OptoSTIM1 causes a change in mice's fear learning behavior without the need of optic fiber implants in the brain.
>> Read more

Rich rewards: Scientists reveal ADHD medication's effect on the brain (Fri, 17 Jan 2020)
Researchers have identified how certain areas of the human brain respond to methylphenidate -- a stimulant drug which is used to treat symptoms of ADHD. The work may help researchers understand the precise mechanism of the drug and ultimately develop more targeted medicines for the condition.
>> Read more

Print Print | Sitemap
© NCPS. Please click here to view our Privacy Policy